Condition
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 7 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownExercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung DiseasesNCT07777367 · 2026-10-01
RECRUITINGExercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Pulmonary Vascular Disease (PVD)NCT07777445 · 2026-10-01
RECRUITINGWhat is the Role of the Exposome in Pulmonary HypertensionNCT07172334 · 2027-01-01
NOT_YET_RECRUITINGVasopressor Agents in Pulmonary Hypertension CrisisNCT07667829 · 2026-06-01
NOT_YET_RECRUITINGA Clinical Study to Find Out if Macitentan is Effective and Safe in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).NCT03809650 · 2019-01-08
TERMINATEDPrevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH)NCT03719027 · 2018-10-30
COMPLETEDU.S. CTEPH RegistryNCT02429284 · 2015-04-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
NOT_YET_RECRUITING2
RECRUITING2
TERMINATED1
Phase mix
NA4
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.